The EU has not yet affected Zhejiang Province due to the blocked export of traditional Chinese Medicine

Business news on April 18: Traditional Chinese medicine is facing the dilemma of withdrawing from the EU plant medicine market According to the directive on the registration procedure of traditional botanical drugs issued by the European Union seven years ago, it is required that all botanical drug manufacturers must complete the registration before April 30, 2011, otherwise they are not allowed to sell and use in the European Union In this regard, the relevant director of the Provincial Association of traditional Chinese medicine industry said that at present, the EU sales ban has not affected the export of traditional Chinese medicine in our province, but it is a warning for the export of traditional Chinese medicine It is reported that up to now, no Chinese medicine enterprise has passed the simplified registration of the European Union Now, there are only more than two weeks left If the registration cannot be completed on time, it means that Chinese medicine enterprises will lose their legal status in the European Union and have to withdraw from the European Union market It is understood that the EU is the world's largest market for botanical drugs, with annual sales of over 10 billion euros, accounting for more than 40% of the world's market share of botanical drugs China's traditional Chinese medicine market in the EU has maintained a good momentum of development The loss of the EU will certainly have a great impact on China's traditional Chinese medicine industry Why didn't Chinese traditional medicine enterprises pass the registration? According to the analysis, one is the high cost of registration It is understood that the single registration cost of Chinese patent medicine is about 1 million yuan, while a traditional Chinese medicine enterprise generally has multiple varieties, and the application fee is relatively high The second is the higher registration requirements of EU According to the traditional botanical medicine registration procedure directive, traditional herbal medicine "must have a medical history of at least 30 years before the application date, including a use history of at least 15 years in the European Union", while the vast majority of Chinese herbal medicine products sold in Europe as non drug identity in China are difficult to provide effective sales certificates in Europe The export of traditional Chinese medicine in our province is not affected "As the EU is not the main market in our province, the order of banning sales has no effect on the export enterprises of traditional Chinese medicine in our province." Yao Zhaili, head of Zhejiang medical and health products import and export company, said that the main export market of our province is Asia, with Hong Kong, Taiwan, Japan and other places as the main ones With the gradual establishment of China ASEAN Free Trade Area, the demand for Chinese herbal medicines, plant extracts and Chinese patent medicines will grow rapidly, and the export of Chinese herbal medicines in our province will be strong Last year, the export of traditional Chinese medicine in our province reached 44.22 million US dollars, an increase of 44.76% year on year In the face of the challenge of entering the EU market, he Bowei, Deputy Secretary General of the Provincial Association of Chinese herbal medicine industry, believes that enterprises in our province can export to the EU through Hong Kong, Taiwan and other places and ASEAN However, according to the requirements of the international development of traditional Chinese Medicine, the cultivation, processing and preparation production of traditional Chinese medicine in our province should make great efforts to ensure the quality, reflect the curative effect and establish a brand In addition, the head of the China Chamber of Commerce for the import and export of medical and health care products under the Ministry of commerce also said that although the deadline for 2011 has passed, China is still collectively striving for a more relaxed time to continue to apply, and the possibility of exporting traditional Chinese medicine to the EU still exists The production of traditional Chinese medicine must be in line with the international standards The failure of Chinese traditional Chinese medicine enterprises to pass the registration is due to the high cost of application for registration and the negative wait-and-see of enterprises At the same time, it is undeniable that it is related to the lagging development of standardization, traditional technology and marketing methods of traditional Chinese medicine industry In this regard, Chinese medicine enterprises themselves should take great responsibility "The EU ban is worthy of the attention of Chinese medicine enterprises entering the international market." According to Shi Haihai, vice president of the association of traditional Chinese medicine industry of Guangdong Province, although the achievements of traditional Chinese medicine in Southeast Asian market are good, as a major province in the production and marketing of traditional Chinese medicine, in the long run, if the industry of traditional Chinese medicine wants to truly go abroad, the traditional production, processing and circulation methods must be in line with international standards This requires the joint efforts of enterprises and relevant departments.